Real-world benefits of biologics for asthma: Exacerbation events and systemic corticosteroid use.

Although the reduction in corticosteroid use did not reach statistical significance in the omalizumab group, significant reductions were achieved in the other 3 groups of biologics.

also in 111,027 other papers